Proprietary potency validation, in vitro screening protocols, and Phase-specific clinical evaluations engineered for international natural product standards and Chilean regulatory alignment.
Analyzing current consumer demand, native botanical valorization, and cross-border raw material dependencies across Santiago, Valparaíso, and Biobío industrial clusters.
Chile represents one of South America's most sophisticated healthcare landscapes. Rising preventative health awareness has catalyzed unprecedented demand for botanical medicines, dietary supplements, and cosmeceuticals targeting metabolic syndrome, cardiovascular health, and cognitive resilience.
While Chile possesses rich endemic assets such as Maqui (Aristotelia chilensis), Boldo (Peumus boldus), and Rosehip (Rosa rubiginosa), commercial extractors frequently struggle with standardized industrial scaling, requiring robust global CDMO partnerships for advanced active fractions.
Local pharmaceutical formulators face intense margin pressure and strict regulatory scrutiny. Manufacturers require thoroughly quantified batch reproducibility, eliminating heavy metal contamination, residual solvent spikes, and botanical adulteration before arrival at Chilean ports.
Navigating the regulatory interface between the Instituto de Salud Pública (ISP), SEREMI de Salud, and international pharmacopeias through systematic empirical audits.
In Chile, finished pharmaceutical products containing plant-derived active ingredients must comply with the strictures of the Instituto de Salud Pública (ISP) under Supreme Decree No. 3 (Decreto Supremo N° 3/2010). Any manufacturer supplying active botanical ingredients must provide verified analytical dossiers, stability profiles according to ICH Zone IV climatic parameters, and comprehensive batch trace documents.
For dietary supplements, functional foods, and nutraceutical tablets, compliance with the Reglamento Sanitario de los Alimentos (RSA - Dto. 977/96) is mandatory. Raw material evaluation requires strict containment thresholds: negative screening for Salmonella and E. coli, total aerobic microbial counts (<10³ CFU/g), and strict quantification of Lead (<0.5 mg/kg), Cadmium (<0.3 mg/kg), Arsenic, and Mercury.
| Evaluation Parameter | Analytical Methodology | ISP / RSA Compliance Target | MedGence Supply Standard |
|---|---|---|---|
| Botanical Identity & Fingerprint | HPTLC, UPLC-DAD, DNA Barcoding | Confirmation against USP/Ph. Eur. / Chilean Monograph | 100% Matching Chromatographic Fingerprint |
| Potency Standardization | HPLC-UV / GC-MS Quantitative Assay | Label claim within 90.0% – 110.0% | Ultra-narrow batch tolerance (±2.0% active target) |
| Heavy Metals (Pb, Cd, As, Hg) | ICP-MS (Inductively Coupled Plasma) | Chilean RSA Dto. 977/96 limits | Pharmaceutical grade (Pb < 0.1ppm, Cd < 0.05ppm) |
| Residual Pesticides | LC-MS/MS & GC-MS/MS (Multi-residue) | European Pharmacopoeia 2.8.13 / Codex Alimentarius | Over 450 screened agrochemicals (Non-Detectable) |
| Solvent Residues | Headspace Gas Chromatography (HS-GC) | ICH Q3C Class 2 & 3 Limits | Ethanol/Water aqueous eco-extraction (<500 ppm) |
Uniting botanical extraction chemistry, deep process modernization of traditional formulas, and world-class contract manufacturing scale.
China commands over 60% of the world's commercial botanical extraction capacity. Deep vertical integration allows real-time geographical and seasonal tracking of active marker compounds—guaranteeing that factors such as altitude, rainfall, and diurnal variation are calibrated before batch harvest.
Moving beyond crude maceration, Chinese manufacturing clusters employ super-critical CO2 extraction, macroporous resin adsorption, nanofiltration, and low-temperature countercurrent extraction. This ensures complete molecular integrity of delicate flavonoids, saponins, and polysaccharides without thermal degradation.
The landmark China-Chile Free Trade Agreement provides tariff exemptions and expedited customs clearing for certified plant derivatives, APIs, and standardized extracts. Coupled with direct Pacific shipping routes to San Antonio and Valparaíso, buyers achieve cost-effective landed economics without intermediaries.
Tailoring active raw materials and custom CDMO development to meet distinct industrial sector requirements throughout the country.
Formulation of instant soluble powders, ready-to-drink (RTD) extracts, and functional waters. Our spray-dried, water-dispersible botanical active powders integrate seamlessly into local Chilean juice and wellness drinks without cloudiness, precipitation, or off-taste notes.
Providing high-purity single-herb extracts and multi-herb synergistic complexes for softgels, standardized coated tablets, and oral tinctures designed for registration as herbal medicines with the ISP, supported by full stability testing.
Anti-aging and barrier-repairing botanical actives engineered for Chile's high-UV exposure climate. Standardized polyphenol fractions, plant oils, and bioactive polysaccharides proven in cellular photoprotection, inflammation mitigation, and melanin inhibition.
Technical insight into how MedGence conducts multi-origin potency evaluation and empirical assay validation to satisfy global pharmaceutical scrutiny.
Natural materials differ profoundly across phenological phases and microclimates. Our laboratory employs high-performance thin-layer chromatography (HPTLC) and ultra-high-performance liquid chromatography (UHPLC) coupled with mass spectrometry to construct definitive chromatographic fingerprints. By comparing retention factors (Rf), peak height ratios, and UV absorption spectra against verified reference standards, we eliminate intentional adulteration (such as spiked synthetic additives) and inadvertent botanical substitution.
Active pharmaceutical ingredients and extracts destined for South America must withstand extreme temperature and relative humidity variations encountered during sea transit and warehouse staging. We subject all extract powders, concentrated liquids, and softgel formulations to accelerated real-time stability testing under ICH Zone IVb conditions (30°C ± 2°C / 75% RH ± 5% RH), ensuring complete stability and lack of hygroscopic degradation.
Speak directly with our senior phytochemists to develop validated analytical testing methods, stability assays, and customized active extraction protocols tailored to your technical project brief.
Explore our full lifecycle contract research, development, active screening, and animal testing solutions optimized for Chilean procurement directors.
Clear, authoritative technical guidance on compliance, import duties, testing timelines, and confidential ODM formulation development.
Partner with China's leading natural medicine CRO & CDMO. Access cutting-edge active screening, validated HPLC protocols, in vitro/in vivo verification, and commercial production under cGMP standards.